These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed. Duncan M, Kendall DA, Ralevic V. J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450 [Abstract] [Full Text] [Related]
8. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth. Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R. Eur J Pharmacol; 2001 May 11; 419(2-3):207-14. PubMed ID: 11426843 [Abstract] [Full Text] [Related]
9. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation. Darmani NA, Sim-Selley LJ, Martin BR, Janoyan JJ, Crim JL, Parekh B, Breivogel CS. Eur J Pharmacol; 2003 Jan 10; 459(1):83-95. PubMed ID: 12505537 [Abstract] [Full Text] [Related]
10. Inhibition of milk ingestion and growth after administration of a neutral cannabinoid CB1 receptor antagonist on the first postnatal day in the mouse. Fride E, Braun H, Matan H, Steinberg S, Reggio PH, Seltzman HH. Pediatr Res; 2007 Nov 10; 62(5):533-6. PubMed ID: 17805201 [Abstract] [Full Text] [Related]
13. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors. Landi M, Croci T, Rinaldi-Carmona M, Maffrand JP, Le Fur G, Manara L. Eur J Pharmacol; 2002 Aug 16; 450(1):77-83. PubMed ID: 12176112 [Abstract] [Full Text] [Related]
15. Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor. Meschler JP, Kraichely DM, Wilken GH, Howlett AC. Biochem Pharmacol; 2000 Nov 01; 60(9):1315-23. PubMed ID: 11008125 [Abstract] [Full Text] [Related]
16. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors. Nieri P, Martinotti E, Testai L, Adinolfi B, Calderone V, Breschi MC. Eur J Pharmacol; 2003 Jan 10; 459(1):75-81. PubMed ID: 12505536 [Abstract] [Full Text] [Related]
17. Effects of cannabinoid receptor agonist and antagonist ligands on production of inflammatory cytokines and anti-inflammatory interleukin-10 in endotoxemic mice. Smith SR, Terminelli C, Denhardt G. J Pharmacol Exp Ther; 2000 Apr 10; 293(1):136-50. PubMed ID: 10734163 [Abstract] [Full Text] [Related]